|Articles|February 22, 2017
Bio-Optronics, OmniComm to Provide Solutions for CRO
OmniComm Systems and Bio-Optromics have reached an agreement with a CRO seeking to develop cancer treatments, for the use of their EDC and CTMS solutions.
Advertisement
OmniComm Systems and Bio-Optromics have reached an agreement with a CRO seeking to develop cancer treatments, for the use of their EDC and CTMS solutions.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Breaking the Efficacy Ceiling in IBD and Beyond
2
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
3
ACT Brief: Substance Versus Branding in Biotech Support, Site-Level Execution Gaps and Point-of-Care Data, and KCNT1-Targeted Pediatric Epilepsy Program
4
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
5